2 Red-Hot Growth Stocks to Buy in 2026

Figma and CoreWeave are highlighted as high-growth AI-exposed companies trading at valuations the author views as reasonable given strong revenue trajectories: Figma generated $749M in 2024 with customers >$10k ARR up 45% to 10,517, a 134% net dollar retention rate, and analysts forecasting a 27% CAGR to $1.53B by 2027 while narrowing losses (projected net loss from $732M to $331M). CoreWeave, which shifted from Ethereum mining to GPU-based AI infrastructure, posted $1.92B revenue in 2024 (up 738%) and street estimates imply a 116% CAGR to $19.2B by 2027; it operates 33 Nvidia-GPU data centers and has large deals with Microsoft and OpenAI but faces near-term debt and dilution risks. Market caps cited are roughly $19B for Figma (about 15x 2026 sales) and $38.1B for CoreWeave (about 3x projected 2026 sales), implying upside if execution and expansion succeed.

Analysis

Market structure: Winners are FIG (designer collaboration SaaS) and CRWV (GPU-native AI infra) along with Nvidia (NVDA) as the choke-point GPU supplier and MSFT/OpenAI as anchor buyers; losers include legacy on-premise design vendors (ADBE’s desktop segment) and generalist cloud providers facing price competition on GPU workloads. Expect downward pressure on per-hour GPU pricing in diversified clouds, but persistent absolute demand for high-end GPUs should keep NVDA pricing power intact and push enterprise capex toward specialized providers over 1–3 years.

Risk assessment: Key tail risks are (1) regulatory intervention (antitrust scrutiny after Adobe/Figma precedent) within 6–24 months, (2) customer concentration for CRWV (top-5 customers >40% revenue risk) and (3) NVDA supply shocks or allocation changes that could delay CRWV expansion. Short-term catalysts: earnings, large-customer contract renewals, and NVDA supply letters in next 3–9 months; long-term risk: if CRWV’s net leverage >4x EBITDA or FIG’s NDR falls below 120%, re-rate downward.

Trade implications: Tactical: accumulate FIG (2–3% portfolio) over 3–6 months as a growth SaaS at ~15x 2026 sales, and build a smaller, higher-conviction CRWV position (1–2%) on any pullback >=15% given 3x 2026 sales and 116% revenue CAGR priced in. Use options: buy CRWV Jan 2027 LEAPS 1–2 year 25–35% OTM call spreads to cap cost; pair trade long FIG / short ADBE (size 1:0.6) to exploit UI/UX share shift.

Contrarian angles: Consensus underestimates the counterparty concentration and capital intensity of CRWV; if NVDA prioritizes hyperscalers, CRWV could face 6–12 month growth hiccups—this downside seems underpriced. Conversely, FIG’s antitrust stigma may be overdone given its independence; a repeatable enterprise upsell (10k customers at $10k ARR growing 45% YoY) could justify >20% upside if NDR stays >130% over 12–24 months.

Key Decisions for Investors

• Establish a 2–3% long position in FIG (NYSE: FIG) over the next 3 months, averaging down on any >10% pullback; exit or trim to zero if net dollar retention (NDR) drops below 120% or YoY revenue growth decelerates below 30% for two consecutive quarters.
• Initiate a high-conviction, risk-sized 1–2% long position in CRWV (NASDAQ: CRWV) using a cost-limited structure: buy 12–24 month LEAP call spreads 25–35% OTM; add increments on confirmed NVDA supply allocations or new multi-quarter deals announced (monitor for top-5 customer concentration >40%).
• Execute a pair trade: long FIG (2%) and short ADBE (1.2%) to play UI/UX share shift; tighten the pair if Adobe reports integration wins or if FIG’s enterprise ARR cohort growth falls below 20% YoY.
• Set hard risk triggers: reduce CRWV exposure by 50% if net leverage exceeds 4x EBITDA or if planned equity dilution in a financing round exceeds 10%; take profits on FIG if valuation >20x 2026 sales or market bids >25% above current price without fundamental upgrades.